Flow Cytometry Market Projected to Reach a Valuation of $16.7 Billion by 2032

It is projected that the global flow cytometry market would increase from US$5.3 billion in fiscal year 2021 to US$6.1 billion in fiscal year 2022. Over the prior year, the industry had an 11% year-over-year increase. It is projected that flow cytometry sales would increase at a compound annual growth rate (CAGR) of 11.1% between 2022 and 2032, reaching a value of US$ 16.7 billion by the end of 2032.

According to historical estimates, the market for flow cytometry services is projected to expand at a compound annual growth rate (CAGR) of 6% between 2015 and 2021. During the same time period, the demand for flow cytometry in the pharmaceutical and drug development industries expanded at a rate of 7.2%. The global market would be dominated by North America, with a potential growth of US$10.2 billion between 2022 and 2032.

For more insights into the Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=4633

Key Drivers Fueling Flow Cytometry Market Growth

The flow cytometry market is expanding due to advancements in immunology and oncology research, along with increasing technological innovations and the rising prevalence of chronic diseases requiring precise diagnostic tools. Researchers utilize flow cytometry for detailed analysis of blood cells, aiding in immunotherapy predictions. The market benefits from high resolution, efficiency, and advanced statistical platforms.

Significant opportunities lie in bioengineering applications, including drug discovery, cell culture, and stem cell therapy. Growing demand for rapid cancer diagnostics and tools to combat infectious diseases further accelerates market growth. Additionally, the expanding life sciences sector and support from healthcare organizations promoting advanced treatments are key factors driving market development.

Competitive Landscape

Leading flow cytometry providers focus on partnerships, collaborations, acquisitions, and innovative software launches to maintain their position in the global market. Continuous advancements aimed at enhancing customer relationships remain a key priority for major players.

• In April 2020, Merck, a prominent science and technology company, introduced the CellStream™ benchtop flow cytometry system. This compact and customizable device uses a camera-based detection system and innovative optics to deliver exceptional sensitivity and flexibility for analyzing cells and submicron particles.
• In July 2021, Thermo Fisher Scientific unveiled the Thermo Scientific Phenom Pharos G2 Desktop Field Emission Gun - Scanning Electron Microscope (FEG-SEM). Designed to advance nanomaterial research, this desktop system offers high resolution and a broad range of acceleration voltages, making it a versatile addition to labs and offices.

Key Segments Covered in the Survey

• By Technology :

  • Cell-based Flow Cytometry
  • Bead-based Flow Cytometry

• By Products & Services :

  • Reagents & Consumables
  • Instruments
  • Software
  • Services

• By Application :

  • Pharmaceutical & Drug Discovery
  • Diagnostics
  • Other Applications

• By End-User :

  • Hospitals & Diagnostic Labs
  • Academic & Research Institutions
  • Other End Users

• By Region :

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com